Genentech
Lodo and Roche go digging for drug candidates, after $1bn deal
May 10, 2018Sales and Marketing Genentech, Roche, biotech, drugs, pharma, pharmaceutical
Discovering potential therapeutics from natural sources has been a constant throughout the evolution of medicine, Lodo Therapeutics, however, has taken …
Five deaths linked to Roche’s haemophilia drug Hemlibra
March 28, 2018Research and Development Genentech, Hemlibra, Roche, haemophilia, pharma
Roche has been rocked by the revelation that there have been five patient deaths linked to the use of its …
Genentech seals deal with DiCE Molecules
December 20, 2017Research and Development, Sales and Marketing DiCE, Genentech, Sanofi, biotech, drugs, pharma, pharmaceutical
Genentech has followed in the footsteps of its parent company by signing a drug discovery agreement with DiCE Molecules. The …
Genentech cements relationship with Arvinas with $650m deal
November 16, 2017Research and Development, Sales and Marketing Arvinas, Genentech, Roche, biotech, drugs, pharma, pharmaceutical
Genentech first signed a deal with Arvinas, a biotech focused on drugs within the protein degradation class, back in 2015. …
South Africa’s over-charging case against Aspen dissolves, remains against big names
October 6, 2017Medical Communications, Sales and Marketing Genentech, Pfizer, Roche, aspen, biotech, drugs, pharma, pharmaceutical
South Africa’s Competition Commission has admitted that there is no case to be heard against Aspen and Equity, in regards …
FDA approves treatment to counter CAR-T side-effects
August 31, 2017Medical Communications, Sales and Marketing Genentech, Roche, biotech, drugs, pharma, pharmaceutical
On the day that FDA announced the first CAR-T therapy would be given market authorisation, it also announced that a …
Roche’s drug scores expanded FDA indication in advanced bladder cancer
April 18, 2017Manufacturing and Production, Sales and Marketing Genentech, Roche, tecentriq
Roche’s Genentech has revealed that its immunotherapy drug Tecentriq (atezolizumab) is now enjoying an expanded indication in the US after …
First treatment for form of MS approved by FDA
March 30, 2017Sales and Marketing Biogen, Genentech, MS, Roche
In big news for sufferers of MS and the company that developed the drug, Roche subsidiary Genetech, the FDA has …
Genentech plans second Phase 3 Alzheimer’s trial following endpoint failures
March 20, 2017Research and Development, Sales and Marketing Alzheimer's, Genentech, Roche
Genentech, Roche’s biotech group, has announced its plans to conduct a second Phase 3 study for crenezumab, its anti-Abeta antibody …
Mylan’s pathway to launch of biosimilar to Herceptin cleared by Roche
March 13, 2017Manufacturing and Production, Sales and Marketing Genentech, Herceptin, Mylan, Roche, biosimilar
Mylan scored a big victory in its plan to launch its biosimilar to Roche’s blockbuster, Herceptin, after Roche and itself …
Genentech oncology head leaves for Bellicum CEO role
February 1, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bellicum, Genentech, Roche, tecentriq
Bellicum Pharmaceuticals has snatched up Genentech’s Rick Fair as its new CEO and President. Fair moves to Bellicum from Genentech …
Juno Therapeutics bring in new executive vice president
January 27, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Genentech, Roche, juno therapeutics
Juno Therapeutics has hired Corsee D. Sanders as its executive vice president and head of development operations. She will step …
Roche’s ground-breaking MS drug delayed by manufacturing issues
December 22, 2016Genentech, MS, Roche, multiple sclerosis
Roche has released both good and bad news just before Christmas. The good news is very good news for individuals …
Genentech announces Bill Anderson as new CEO
December 16, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bill Anderson, Genentech, Roche
Genentech, the biotech subsidiary of Roche, has announced that Genentech veteran, Ian Clark, will retire as CEO on 1 January. …
Roche’s immunotherapy cancer drug given FDA approval
October 19, 2016Research and Development Cancer, FDA, Genentech, Roche, immunotherapy, lung cancer
Coming off the back of earlier positive news this month, Roche has revealed that their drug, Tecentriq, has been given …
Latest content
Five Facts about cardiovascular disease
